citalopram and nortriptyline

citalopram has been researched along with nortriptyline in 94 studies

Research

Studies (94)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (4.26)	18.7374
1990's	4 (4.26)	18.2507
2000's	21 (22.34)	29.6817
2010's	62 (65.96)	24.3611
2020's	3 (3.19)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H	1
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J	1
Lombardo, F; Obach, RS; Waters, NJ	1
Ahman, M; Holmén, AG; Wan, H	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Glen, RC; Lowe, R; Mitchell, JB	1
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Barnes, JM; Barnes, NM; Champaneria, S; Costall, B; Hornsby, CD; Naylor, RJ	1
Insel, TR; Winslow, JT	1
Abbiati, GA; Angelico, P; Testa, R	1
Abbiati, G; Ibba, M; Schiavi, S; Testa, R	1
Bolwig, TG; Clemmesen, L; Jensen, E; Min, SK; Rafaelsen, OJ	1
Bjerre, M; Gram, LF; Kragh-Sørensen, P; Overø, KF; Pedersen, OL	1
Abel, EL	1
Meyers, BS	1
Gastó, C; Marcos, T; Navarro, V; Pintor, L; Torres, X	1
Gastó, C; Marcos, T; Navarro, V; Portella, MJ; Rami, L; Salamero, M	1
Gastó, C; Lázaro, L; Marcos, T; Navarro, V; Portella, MJ; Rami, L; Salamero, M	1
Alpert, JE; Biggs, M; Fava, M; Luther, JF; McGrath, PJ; Niederehe, G; Nierenberg, AA; Ritz, L; Rush, AJ; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR	1
Dirks, AC; van Hyfte, DM	1
Mizrahi, R; Power, BD; Starkstein, SE	1
Aitchison, KJ; D'Souza, UM; McGuffin, P; Pariante, CM; Sugden, K	1
Aitchison, KJ; Barreto, M; Dmitrzak-Weglarz, M; Elkin, A; Farmer, A; Giovannini, C; Hauser, J; Henigsberg, N; Jorgensen, L; Kalember, P; Landau, S; Maier, W; Marusic, A; McGuffin, P; Mors, O; Petrovic, A; Placentino, A; Rietschel, M; Schmael, C; Souery, D; Uher, R; Zobel, A	1
Aitchison, KJ; Dernovsek, MZ; Farmer, A; Gunasinghe, C; Hauser, J; Henigsberg, N; Kalember, P; Kozel, D; Larsen, ER; Leszczynska-Rodziewicz, A; Linotte, S; Maier, W; McGuffin, P; Mors, O; Pedrini, L; Perroud, N; Placentino, A; Rietschel, M; Souery, D; Strohmaier, J; Uher, R; Zobel, A	1
Aitchison, KJ; Barreto, M; Craig, I; Czerski, PM; Dernovsek, MZ; Farmer, A; Giovannini, C; Gray, JM; Hauser, J; Henigsberg, N; Huezo-Diaz, P; Kalember, P; Kozel, D; Larsen, ER; Lewis, CM; Maier, W; McGuffin, P; Mors, O; Perroud, N; Placentino, A; Rietschel, M; Schulze, TG; Smith, R; Souery, D; Uher, R; Zobel, A	1
Aitchison, KJ; Craig, I; Czerski, PM; Farmer, A; Gupta, B; Hauser, J; Henigsberg, N; Hoda, F; Huezo-Diaz, P; Larsen, ER; Maier, W; Marusic, A; McGuffin, P; Mors, O; Perroud, N; Placentino, A; Rietschel, M; Smith, R; Souery, D; Uher, R; Zobel, A	1
Aitchison, KJ; Bonvicini, C; Craig, I; Farmer, AE; Gray, J; Gupta, B; Hauser, J; Henigsberg, N; Huezo-Diaz, P; Jorgensen, L; Kalember, P; Kapelski, P; Lewis, CM; Maier, W; Marusic, A; McGuffin, P; Mors, O; Perroud, N; Petrovic, A; Placentino, A; Rietschel, M; Schulze, TG; Smith, R; Souery, D; Uher, R; Zobel, A	1
Aitchison, KJ; Barreto, M; Dernovsek, MZ; Farmer, A; Giovannini, C; Hauser, J; Henigsberg, N; Kalember, P; Kozel, D; Larsen, ER; Maier, W; McGuffin, P; Mors, O; Perroud, N; Placentino, A; Rajewska-Rager, A; Rietschel, M; Souery, D; Strohmaier, J; Uher, R; Zobel, A	1
Aitchison, KJ; Dmitrzak-Weglarz, M; Farmer, A; Giovannini, C; Hauser, J; Henigsberg, N; Jorgensen, L; Kovacic, Z; Kozel, D; Maier, W; McGuffin, P; Mendlewicz, J; Mors, O; Perroud, N; Placentino, A; Rietschel, M; Souery, D; Strohmaier, J; Uher, R; Zobel, A	1
Aitchison, KJ; Campbell, D; Elkin, A; Farmer, AE; Giovannini, C; Gray, J; Gunasinghe, C; Gupta, B; Hauser, J; Henigsberg, N; Jorgensen, L; Maier, W; Marusic, A; McGuffin, P; Mors, O; Perroud, N; Placentino, A; Rietschel, M; Souery, D; Strohmaier, J; Szczepankiewicz, A; Uher, R; Zobel, A	1
Aitchison, KJ; Farmer, A; Henigsberg, N; Jaracz, J; McGuffin, P; Mors, O; Muthén, B; Petrovic, A; Placentino, A; Rietschel, M; Souery, D; Uher, R; Zobel, A	1
Aitchison, KJ; Craig, I; Dmitrzak-Weglarz, M; Farmer, AE; Gupta, B; Hauser, J; Henigsberg, N; Hoda, F; Huezo-Diaz, P; Jaffee, S; Keers, R; Kozel, D; Larsen, ER; Maier, W; McGuffin, P; Mors, O; Placentino, A; Rietschel, M; Smith, R; Souery, D; Uher, R; Zobel, A	1
Aitchison, KJ; Barnes, MR; Breen, G; Butler, AW; Cohen-Woods, S; Craig, I; Czerski, PM; Farmer, A; Hauser, J; Henigsberg, N; Jerman, B; Larsen, ER; Lathrop, M; Lewis, CM; Maier, W; McGuffin, P; Mors, O; Muglia, P; Ng, MY; Perroud, N; Pirlo, K; Placentino, A; Rietschel, M; Schulze, TG; Souery, D; Uher, R; Zagar, T; Zobel, A	1
Bär, KJ; Höfels, S; Maier, W; Schuhmacher, A; Schulz, S; Voss, A; Yeragani, VK; Zobel, A	1
Bauriedel, G; Flöck, A; Hammerstingl, C; Höfels, S; Maier, W; Nickenig, G; Schuhmacher, A; Skowasch, D; Tuleta, I; Zobel, A	1
Becchi, S; Carboni, L; Domenici, E; Giambelli, R; Mallei, A; Mathé, AA; Piubelli, C; Popoli, M; Razzoli, M	1
Aitchison, KJ; Farmer, AE; Giovannini, C; Gupta, B; Hauser, J; Henigsberg, N; Kalember, P; Keers, R; Kozel, D; Kristensen, AS; Kumar, S; Maier, W; McGuffin, P; Mendlewicz, J; Mors, O; Rietschel, M; Schulze, TG; Skibinska, M; Uher, R; Zobel, A	1
Aitchison, KJ; Dernovsek, MZ; Farmer, A; Gray, JM; Hauser, J; Henigsberg, N; Kalember, P; Keers, R; Kozel, D; Larsen, ER; Maier, W; McGuffin, P; Mendlewicz, J; Mors, O; Placentino, A; Rietschel, M; Souery, D; Strohmaier, J; Szczepankiewicz, A; Uher, R; Zobel, A	1
Aitchison, KJ; Bonvicini, C; Craig, I; Elkin, A; Farmer, AE; Gennarelli, M; Giovannini, C; Hauser, J; Henigsberg, N; Keers, R; Kovacic, Z; Kozel, D; Larsen, ER; Maier, W; McGuffin, P; Mendlewicz, J; Mors, O; Placentino, A; Rietschel, M; Scassellati, C; Schmäl, C; Souery, D; Szczepankiewicz, A; Uher, R; Zobel, A	1
Aitchison, KJ; Breen, G; Craig, IW; Dernovsek, MZ; Farmer, A; Gennarelli, M; Guipponi, M; Hauser, J; Henigsberg, N; Lathrop, M; Lewis, CM; Maier, W; McGuffin, P; Mors, O; Ng, MY; Perroud, N; Rietschel, M; Souery, D; Stamp, AS; Uher, R	1
Aitchison, KJ; Binder, E; Cohen-Woods, S; Craig, IW; Farmer, A; Hauser, J; Henigsberg, N; Jerman, B; Lewis, CM; Malki, K; McGuffin, P; Mors, O; Ng, MY; Paya-Cano, J; Placentino, A; Rietschel, M; Schalkwyk, LC; Sluyter, F; Souery, D; Uher, R; Zobel, A	1
Hansson, AC; Heilig, M; Mathé, AA; Rimondini, R; Sommer, WH	1
Aitchison, KJ; Dernovsek, MZ; Farmer, A; Hauser, J; Henigsberg, N; Kozel, D; McGuffin, P; Mors, O; Placentino, A; Rietschel, M; Schmäl, C; Souery, D; Streit, F; Strohmaier, J; Uher, R; Wüst, S; Zobel, A	1
Aitchison, KJ; Dernovsek, MZ; Farmer, A; Hauser, J; Henigsberg, N; Kalember, P; Maier, W; McGuffin, P; Mendlewicz, J; Mors, O; Placentino, A; Rietschel, M; Souery, D; Uher, R; Zobel, A	1
Aitchison, KJ; Bajs, M; Dernovsek, MZ; Farmer, A; Hauser, J; Henigsberg, N; Maier, W; McGuffin, P; Mors, O; Perlis, RH; Rietschel, M; Souery, D; Uher, R; Zobel, A	1
Aitchison, KJ; Binder, E; Fernandes, C; Malki, K; Mathé, AA; Paya-Cano, JL; Schalkwyk, LC; Sluyter, F	1
Aitchison, KJ; Farmer, A; Henigsberg, N; McGuffin, P; Mendlewicz, J; Mors, O; Petrovic, A; Rajewska-Rager, A; Rietschel, M; Uher, R; Zobel, A	1
Dean, D; Desrosiers, NA; Watterson, JH; Wyman, JF	1
Carver, S; Dernovsek, MZ; Farmer, A; Hauser, J; Henigsberg, N; Maier, W; McGuffin, P; Mors, O; Placentino, A; Power, RA; Rietschel, M; Souery, D; Uher, R	1
Andersen, PK; Andersson, C; Folke, F; Fosbøl, EL; Gerds, T; Gislason, GH; Jensen, A; Kanters, JK; Køber, L; Larsen, JK; Lippert, FK; Nielsen, SL; Olesen, JB; Pehrson, S; Poulsen, HE; Torp-Pedersen, C; Weeke, P	1
Aitchinson, KJ; Binder, E; Campbell, J; Craig, I; Davies, M; Keers, R; Kuhn, K; Malki, K; McGuffin, P; Paya-Cano, J; Schalkwyk, LC; Selzer, S; Sluyter, F; Uher, R; Ward, M	1
Henigsberg, N; Lewis, CM; Maier, W; McGuffin, P; Mendlewicz, J; Mors, O; Muthén, B; Placentino, A; Power, RA; Uher, R	1
Dernovšek, MZ; Farmer, A; Henigsberg, N; Maier, W; McGuffin, P; Mors, O; Perlis, RH; Placentino, A; Uher, R	1
Binder, E; Craig, I; Keers, R; Lourdusamy, A; Malki, K; McGuffin, P; Payá-Cano, J; Schalkwyk, LC; Sluyter, F; Uher, R	1
Jensen, K	1
Torp-Pedersen, C; Weeke, P	1
Allerup, P; Bech, P; Csillag, C; Larsen, ER; Licht, RW	1
McGuffin, P; Mors, O; Uher, R	1
Hackinger, S; McGuffin, P; Mill, J; Powell, TR; Schalkwyk, LC; Smith, RG; Tansey, KE; Uher, R	1
Aitchison, KJ; Belsey, S; Belsy, S; Craig, IW; Davis, OS; Dernovsek, MZ; Farmer, AE; Hauser, J; Henigsberg, N; Hodgson, K; Maier, W; McGuffin, P; Mors, O; Placentino, A; Rietschel, M; Smith, R; Souery, D; Tansey, K; Uher, R	1
Blumenthal, SR; Castro, VM; Churchill, SE; Clements, CC; Erb, JL; Fava, M; Kohane, IS; Murphy, SN; Perlis, RH; Rosenfield, HR; Smoller, JW; Weilburg, JB	1
Dernovsek, MZ; Dew, T; Farmer, A; Hauser, J; Henigsberg, N; Maier, W; McGuffin, P; Mors, O; Souery, D; Tansey, KE; Uher, R	1
Uher, R	1
Kronenberg, G; Kunte, H; Rentzsch, J	1
Aitchison, KJ; Craig, IW; Dernovšek, MZ; Dobson, RJ; Farmer, AE; Hauser, J; Henigsberg, N; Hodgson, K; Maier, W; McGuffin, P; Mors, O; Placentino, A; Rietschel, M; Souery, D; Tansey, KE; Uher, R	1
Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N	1
Buttenschøn, HN; Elfving, B; Foldager, L; Mors, O; Poulsen, PH; Uher, R	1
Barnes, J; Boon, HS; Cvijovic, K; Foster, BC; Jaeger, W; Liu, R; Murty, M; Tam, TW; Tsuyuki, RT; Vohra, S; Vu, D	1
Bech, P; Bendsen, BB; Brødsgaard, I; Buchholtz, PE; Christensen, EM; Damkier, P; Eftekhari, SZ; Gram, LF; Holmskov, J; Klysner, R; Larsen, ER; Larsen, JK; Licht, RW; Lolk, A; Lunde, M; Martiny, K; Nielsen, CT; Refsgaard, E; Straasø, B; Sørensen, CH; Terp, IM; Vestergaard, P	1
Aitchison, KJ; Breen, G; Coppola, G; Craig, IW; Dobson, R; Farmer, AE; Hauser, J; Henigsberg, N; Hodgson, K; Maier, W; McGuffin, P; Mors, O; Placentino, A; Powell, TR; Rietschel, M; Souery, D; Tansey, KE; Uher, R; Zvezdana Dernovšek, M	1
Aitchison, KJ; Dernovsek, MZ; Dobson, R; Farmer, A; Hauser, J; Henigsberg, N; Iniesta, R; Lewis, CM; Maier, W; Malki, K; McGuffin, P; Mors, O; Rietschel, M; Souery, D; Stahl, D; Uher, R	1
Bocchio-Chiavetto, L; Cattaneo, A; Ferrari, C; Pariante, CM; Riva, MA; Uher, R	1
Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X	1
Bryson, K; Carboni, L; Herbster, M; Jumhaboy, I; Liu, T; Malki, K; Malykh, A; McGuffin, P; Mouriño-Talín, H; Newman, S; Pain, O; Parpas, P; Rodríguez-Lorenzo, S; Schalkwyk, LC; Tosto, MG; Uher, R	1
Breen, G; Lee, SH; Murphy, T; Powell, TR; Price, J; Thuret, S	1
Gattner, K; Górna, K; Hauser, J; Jaracz, J; Jaracz, K; Moczko, J	1
Aitchison, KJ; Dernovsek, MZ; Dobson, R; Farmer, A; Hauser, J; Henigsberg, N; Hodgson, K; Iniesta, R; Lewis, CM; Maier, W; Malki, K; McGuffin, P; Mors, O; Rietschel, M; Souery, D; Stahl, D; Uher, R	1
Aitchison, KJ; Fabbri, C; Farmer, A; Hauser, J; Lewis, CM; Maier, W; McGuffin, P; Mors, O; Rietschel, M; Uher, R; Zobel, A; Zwicker, A	1
Angelucci, F; El Khoury, A; Ellenbroek, BA; Mathé, AA	1
Aitchison, KJ; Buttenschøn, HN; Farmer, A; Hauser, J; Köhler-Forsberg, O; Larsen, ER; Maier, W; McGuffin, P; Mors, O; Rietschel, M; Souery, D; Uher, R	1
Arnold, PD; Bousman, C; Greenslade, A; Maruf, AA	1
Aitchison, KJ; Behrendt-Møller, I; Buttenschøn, HN; Dernovsek, MZ; Hauser, J; Henigsberg, N; Köhler-Forsberg, O; Madsen, T; Maier, W; McGuffin, P; Mors, O; Perroud, N; Rietschel, M; Souery, D; Uher, R	1
Emsley, R; Hellier, J; Pickles, A	1
Aboushawareb, SAE; Barnett, TA; Bartlett, G; Kudrina, I; Puzhko, S; Renoux, C; Schuster, T	1
Carboni, L; Domenici, E; Lauria, M; Mathé, AA; Musazzi, L; Piccoli, G; Pischedda, F; Popoli, M	1

Reviews

6 review(s) available for citalopram and nortriptyline

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Depression and dementia: comorbidities, identification, and treatment. Journal of geriatric psychiatry and neurology, 1998,Winter, Volume: 11, Issue:4 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cognition Disorders; Comorbidity; Dementia; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline	1998
Antidepressant therapy in post-stroke depression. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:8 Topics: Antidepressive Agents; Citalopram; Controlled Clinical Trials as Topic; Depressive Disorder; Humans; Nortriptyline; Prognosis; Sertraline; Stroke; Treatment Outcome	2008
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet (London, England), 2016, Aug-27, Volume: 388, Issue:10047 Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride	2016
Antidepressant pharmacogenetics in children and young adults: A systematic review. Journal of affective disorders, 2019, 07-01, Volume: 254 Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mental Disorders; Nortriptyline; Paroxetine; Pharmacogenetics; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tryptophan Hydroxylase; Venlafaxine Hydrochloride; Young Adult	2019
Excess body weight as a predictor of response to treatment with antidepressants in patients with depressive disorder. Journal of affective disorders, 2020, 04-15, Volume: 267 Topics: Adult; Antidepressive Agents; Body Weight; Citalopram; Depressive Disorder; Humans; Nortriptyline	2020

Trials

33 trial(s) available for citalopram and nortriptyline

Article	Year
Citalopram versus nortriptyline in late-life depression: a 12-week randomized single-blind study. Acta psychiatrica Scandinavica, 2001, Volume: 103, Issue:6 Topics: Age of Onset; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder; Female; Geriatric Psychiatry; Humans; Male; Middle Aged; Nortriptyline; Patient Compliance; Single-Blind Method; Treatment Outcome	2001
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STARD report. The American journal of psychiatry, 2006, Volume: 163, Issue:7* Topics: Adult; Ambulatory Care; Antidepressive Agents, Tricyclic; Bupropion; Citalopram; Cross-Over Studies; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; Mianserin; Middle Aged; Mirtazapine; Nortriptyline; Personality Inventory; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome	2006
Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. The British journal of psychiatry : the journal of mental science, 2009, Volume: 194, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Humans; Male; Middle Aged; Nortriptyline; Psychiatric Status Rating Scales; Treatment Outcome; Young Adult	2009
Body weight as a predictor of antidepressant efficacy in the GENDEP project. Journal of affective disorders, 2009, Volume: 118, Issue:1-3 Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Appetite; Body Mass Index; Body Weight; Citalopram; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Nortriptyline; Obesity; Overweight; Sleep; Treatment Outcome	2009
Moderation of antidepressant response by the serotonin transporter gene. The British journal of psychiatry : the journal of mental science, 2009, Volume: 195, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Alleles; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder; Female; Genotype; Humans; Male; Middle Aged; Nortriptyline; Polymorphism, Single Nucleotide; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sex Factors; Young Adult	2009
Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:12 Topics: Adult; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Depressive Disorder, Major; Female; Follow-Up Studies; Genetic Predisposition to Disease; Haplotypes; Humans; Linkage Disequilibrium; Logistic Models; Male; Nortriptyline; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Receptor, trkB; Receptors, Adrenergic, alpha-2; Sex Factors; Suicide	2009
Adverse reactions to antidepressants. The British journal of psychiatry : the journal of mental science, 2009, Volume: 195, Issue:3 Topics: Adult; Aged; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Humans; Male; Middle Aged; Nortriptyline; Patient Acceptance of Health Care; Psychiatric Status Rating Scales; Severity of Illness Index; Statistics as Topic; Surveys and Questionnaires; Time Factors; Urinary Retention; Xerostomia; Young Adult	2009
History of suicide attempts among patients with depression in the GENDEP project. Journal of affective disorders, 2010, Volume: 123, Issue:1-3 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Comorbidity; Depressive Disorder, Major; Europe; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Middle Aged; Nortriptyline; Personality Assessment; Risk Factors; Suicide, Attempted	2010
Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial. BMC medicine, 2009, Oct-15, Volume: 7 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder; Female; Humans; Male; Middle Aged; Nortriptyline; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Suicide; Young Adult	2009
Trajectories of change in depression severity during treatment with antidepressants. Psychological medicine, 2010, Volume: 40, Issue:8 Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Europe; Female; Follow-Up Studies; Genotype; Humans; Male; Middle Aged; Nortriptyline; Personality Inventory; Pharmacogenetics; Psychometrics; Receptors, Adrenergic; Receptors, Serotonin; Recurrence; Reproducibility of Results; Weights and Measures	2010
Antiplatelet effects of antidepressant treatment: a randomized comparison between escitalopram and nortriptyline. Thrombosis research, 2010, Volume: 126, Issue:2 Topics: Adult; Antidepressive Agents; Blood Platelets; Citalopram; Depression; Female; Humans; Male; Middle Aged; Nortriptyline; Platelet Aggregation	2010
Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP. Journal of affective disorders, 2010, Volume: 127, Issue:1-3 Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cognition Disorders; Depressive Disorder, Major; Female; Humans; Life Change Events; Longitudinal Studies; Male; Mental Status Schedule; Middle Aged; Nortriptyline; Pharmacogenetics	2010
Changes in body weight during pharmacological treatment of depression. The international journal of neuropsychopharmacology, 2011, Volume: 14, Issue:3 Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Body Mass Index; Body Weight; Citalopram; Depressive Disorder; Female; Humans; Male; Middle Aged; Nortriptyline; Obesity; Selective Serotonin Reuptake Inhibitors; Weight Gain; Weight Loss; Young Adult	2011
Variation in GNB3 predicts response and adverse reactions to antidepressants. Journal of psychopharmacology (Oxford, England), 2011, Volume: 25, Issue:7 Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Europe; Female; Gene Frequency; Haplotypes; Heterotrimeric GTP-Binding Proteins; Humans; Linkage Disequilibrium; Male; Middle Aged; Nortriptyline; Pharmacogenetics; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Risk Assessment; Risk Factors; Sleep Initiation and Maintenance Disorders; Time Factors; Treatment Outcome; Weight Gain	2011
Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project. The pharmacogenomics journal, 2012, Volume: 12, Issue:1 Topics: Adult; Aged; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Female; Genome-Wide Association Study; Humans; Male; Middle Aged; Nortriptyline; Polymorphism, Single Nucleotide; Suicidal Ideation; Time Factors; Treatment Outcome; Young Adult	2012
Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants. Biological psychiatry, 2011, Feb-15, Volume: 69, Issue:4 Topics: Adult; Aged; Animals; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Gene Expression; Genotype; Hippocampus; Humans; Male; Mice; Mice, Inbred Strains; Middle Aged; Nortriptyline; Phosphoprotein Phosphatases; Polymorphism, Genetic; Protein Phosphatase 2C; RNA, Messenger	2011
Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2011, Volume: 12, Issue:7 Topics: Adrenergic Uptake Inhibitors; Adult; Alleles; Citalopram; Depressive Disorder, Major; Female; Genotype; Humans; Male; Middle Aged; Nortriptyline; Pharmacogenetics; Promoter Regions, Genetic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sexual Dysfunction, Physiological	2011
Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. Journal of affective disorders, 2011, Volume: 132, Issue:1-2 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Citalopram; Depressive Disorder; Female; Humans; Male; Middle Aged; Nortriptyline; Personality Inventory; Prognosis; Psychometrics; Somatoform Disorders	2011
Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychological medicine, 2012, Volume: 42, Issue:5 Topics: Activities of Daily Living; Adult; Affect; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cognition; Depressive Disorder, Major; Europe; Factor Analysis, Statistical; Female; Humans; Male; Nortriptyline; Predictive Value of Tests; Psychiatric Status Rating Scales; Reproducibility of Results; Severity of Illness Index; Treatment Outcome	2012
Non-steroidal anti-inflammatory drugs and efficacy of antidepressants in major depressive disorder. Psychological medicine, 2012, Volume: 42, Issue:10 Topics: Adult; Age Distribution; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Drug Interactions; Female; Humans; Male; Middle Aged; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sex Distribution; Treatment Outcome	2012
Self-report and clinician-rated measures of depression severity: can one replace the other? Depression and anxiety, 2012, Volume: 29, Issue:12 Topics: Adult; Aged; Antidepressive Agents; Citalopram; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Nortriptyline; Observer Variation; Predictive Value of Tests; Psychiatric Status Rating Scales; Psychometrics; Self Report; Severity of Illness Index; Treatment Outcome	2012
DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP. Translational psychiatry, 2013, Sep-03, Volume: 3 Topics: Adult; Aged; Antidepressive Agents; Citalopram; CpG Islands; Depressive Disorder, Major; DNA Methylation; Epigenesis, Genetic; Female; Humans; Interleukin-11; Male; Middle Aged; Nortriptyline; Regression Analysis; Treatment Outcome; Young Adult	2013
Genetic differences in cytochrome P450 enzymes and antidepressant treatment response. Journal of psychopharmacology (Oxford, England), 2014, Volume: 28, Issue:2 Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Genotype; Humans; Nortriptyline	2014
An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. The American journal of psychiatry, 2014, Dec-01, Volume: 171, Issue:12 Topics: Academic Medical Centers; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Biomarkers; C-Reactive Protein; Citalopram; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Europe; Female; Humans; Inflammation; Male; Middle Aged; Nortriptyline; Predictive Value of Tests; Psychiatric Status Rating Scales; Research Design; Severity of Illness Index; Treatment Outcome	2014
Relapse Prevention in Major Depressive Disorder After Successful Acute Electroconvulsive Treatment: a 6-month Double-blind Comparison of Three Fixed Dosages of Escitalopram and a Fixed Dose of Nortriptyline - Lessons from a Failed Randomised Trial of the Pharmacopsychiatry, 2015, Volume: 48, Issue:7 Topics: Adult; Aged; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Double-Blind Method; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Nortriptyline; Secondary Prevention; Treatment Outcome	2015
Transcriptomics and the mechanisms of antidepressant efficacy. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2016, Volume: 26, Issue:1 Topics: Antidepressive Agents; Carrier Proteins; Citalopram; Cohort Studies; Depressive Disorder, Major; Europe; Gene Expression; Humans; Matrix Metalloproteinases, Secreted; Microarray Analysis; Nortriptyline; Transcriptome; Treatment Outcome; White People	2016
Combining clinical variables to optimize prediction of antidepressant treatment outcomes. Journal of psychiatric research, 2016, Volume: 78 Topics: Age Factors; Antidepressive Agents; Area Under Curve; Body Mass Index; Citalopram; Depressive Disorder, Major; Female; Humans; Machine Learning; Male; Nortriptyline; Personality; Precision Medicine; Prognosis; Psychiatric Status Rating Scales; Regression Analysis; Treatment Outcome	2016
Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients. The international journal of neuropsychopharmacology, 2016, Volume: 19, Issue:10 Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cell-Free Nucleic Acids; Citalopram; Depressive Disorder, Major; Discriminant Analysis; Female; Gene Expression Profiling; Humans; Interleukin-1beta; Intramolecular Oxidoreductases; Linear Models; Logistic Models; Macrophage Migration-Inhibitory Factors; Male; Middle Aged; Multivariate Analysis; Nortriptyline; Predictive Value of Tests; Protein Interaction Maps; RNA, Messenger; Time Factors; Treatment Outcome	2016
Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables. Scientific reports, 2018, 04-03, Volume: 8, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Biomarkers; Citalopram; Depressive Disorder, Major; Female; Humans; Male; Nortriptyline; Treatment Outcome	2018
Genetic disposition to inflammation and response to antidepressants in major depressive disorder. Journal of psychiatric research, 2018, Volume: 105 Topics: Adrenergic Uptake Inhibitors; Adult; C-Reactive Protein; Citalopram; Depressive Disorder, Major; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Inflammation; Male; Meta-Analysis as Topic; Middle Aged; Nortriptyline; Pharmacogenetics; Risk Assessment; Selective Serotonin Reuptake Inhibitors	2018
Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder. The British journal of psychiatry : the journal of mental science, 2019, Volume: 215, Issue:2 Topics: Adult; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Drug Substitution; Drug Utilization; Europe; Female; Humans; Linear Models; Logistic Models; Male; Middle Aged; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Treatment Failure	2019
Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive Disorder. The Journal of clinical psychiatry, 2019, 07-16, Volume: 80, Issue:4 Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Europe; Female; Humans; Male; Nortriptyline; Suicidal Ideation; Suicide; Suicide Prevention; Treatment Outcome	2019
Estimating dose-response for time to remission with instrumental variable adjustment: the obscuring effects of drug titration in Genome Based Therapeutic Drugs for Depression Trial (GENDEP): clinical trial data. Trials, 2020, Jan-03, Volume: 21, Issue:1 Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depression; Female; Humans; Male; Nortriptyline; Remission Induction; Severity of Illness Index; Treatment Outcome	2020

Other Studies

55 other study(ies) available for citalopram and nortriptyline

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery. Journal of medicinal chemistry, 2007, Sep-20, Volume: 50, Issue:19 Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats	2007
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2 Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs. Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6 Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
Species independence in brain tissue binding using brain homogenates. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7 Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity	2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Pharmacological comparison of the rat and guinea-pig cortical high affinity 5-hydroxytryptamine uptake system. Biochemical pharmacology, 1992, Apr-15, Volume: 43, Issue:8 Topics: Amitriptyline; Animals; Binding, Competitive; Cerebral Cortex; Citalopram; Desipramine; Female; Guinea Pigs; Kinetics; Nortriptyline; Rats; Serotonin; Synaptosomes	1992
Serotonergic and catecholaminergic reuptake inhibitors have opposite effects on the ultrasonic isolation calls of rat pups. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1990, Volume: 3, Issue:1 Topics: Animals; Body Temperature; Catecholamines; Citalopram; Clomipramine; Desipramine; Flumazenil; Mazindol; Motor Activity; Naltrexone; Nortriptyline; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin Antagonists; Stress, Psychological; Ultrasonics; Vocalization, Animal	1990
Effect of citalopram, amineptine, imipramine and nortriptyline on stress-induced (footshock) analgesia in rats. Pain, 1987, Volume: 29, Issue:2 Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Citalopram; Dibenzocycloheptenes; Dose-Response Relationship, Drug; Electroshock; Hindlimb; Imipramine; Male; Nortriptyline; Pain; Propylamines; Rats; Rats, Inbred Strains	1987
Effects of oral administration of nortriptyline, imipramine and citalopram on morphine hot-plate and tail-immersion analgesia in rats. Bollettino chimico farmaceutico, 1987, Volume: 126, Issue:2 Topics: Analgesia; Animals; Antidepressive Agents; Citalopram; Drug Interactions; Imipramine; Male; Morphine; Nortriptyline; Propylamines; Rats; Reaction Time	1987
Salivation after single-doses of the new antidepressants femoxetine, mianserin and citalopram. A cross-over study. Pharmacopsychiatry, 1984, Volume: 17, Issue:4 Topics: Adolescent; Adult; Antidepressive Agents; Citalopram; Dibenzazepines; Female; Flupenthixol; Humans; Male; Mianserin; Nortriptyline; Piperidines; Propylamines; Random Allocation; Salivation; Serotonin Antagonists	1984
Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect--a phase II study. Psychopharmacology, 1982, Volume: 77, Issue:3 Topics: Adult; Citalopram; Depressive Disorder; Drug Evaluation; Electroconvulsive Therapy; Female; Humans; Kinetics; Male; Middle Aged; Nortriptyline; Propylamines; Psychiatric Status Rating Scales; Serotonin Antagonists	1982
Alpha-adrenergic receptors mediate imipramine/alarm substance-induced reaction in rats. Physiology & behavior, 1994, Volume: 56, Issue:2 Topics: Animals; Arousal; Brain; Citalopram; Clonidine; Dose-Response Relationship, Drug; Imipramine; Male; Norepinephrine; Nortriptyline; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, alpha-2; Receptors, GABA; Reserpine; Serotonin; Yohimbine	1994
Residual cognitive impairment in late-life depression after a 12-month period follow-up. International journal of geriatric psychiatry, 2003, Volume: 18, Issue:7 Topics: Aged; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cognition Disorders; Depressive Disorder; Female; Follow-Up Studies; Geriatric Assessment; Humans; Male; Middle Aged; Neuropsychological Tests; Nortriptyline; Prospective Studies	2003
Neuropsychological prediction of recovery in late-onset major depression. International journal of geriatric psychiatry, 2005, Volume: 20, Issue:8 Topics: Age of Onset; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cognition; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Male; Memory; Neuropsychological Tests; Nortriptyline; Predictive Value of Tests; Recovery of Function; Treatment Outcome; Verbal Learning	2005
Recurrent hyponatremia after substitution of citalopram with duloxetine. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:3 Topics: Aged, 80 and over; Antidepressive Agents, Tricyclic; Citalopram; Depression; Duloxetine Hydrochloride; Female; Humans; Hyponatremia; Nortriptyline; Recurrence; Selective Serotonin Reuptake Inhibitors; Thiophenes	2007
Housekeeping gene expression is affected by antidepressant treatment in a mouse fibroblast cell line. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:8 Topics: Animals; Antidepressive Agents; beta 2-Microglobulin; Cell Line; Citalopram; Cytochromes c1; Gene Expression; Gene Expression Profiling; Genetic Markers; Mice; Mitochondrial Proton-Translocating ATPases; Nortriptyline; Polymerase Chain Reaction	2010
Genetic predictors of response to antidepressants in the GENDEP project. The pharmacogenomics journal, 2009, Volume: 9, Issue:4 Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Humans; Linkage Disequilibrium; Norepinephrine Plasma Membrane Transport Proteins; Nortriptyline; Pharmacogenetics; Receptor, Serotonin, 5-HT2A; Receptors, Glucocorticoid; Selective Serotonin Reuptake Inhibitors	2009
Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project. The pharmacogenomics journal, 2011, Volume: 11, Issue:2 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Drug Resistance; Female; Genotype; Humans; Life Change Events; Male; Middle Aged; Multicenter Studies as Topic; Nortriptyline; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Young Adult	2011
Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. The American journal of psychiatry, 2010, Volume: 167, Issue:5 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder; Depressive Disorder, Major; Genome-Wide Association Study; Genotype; Humans; Interleukin-11; Interleukin-6; Nortriptyline; Oligonucleotide Array Sequence Analysis; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Sulfotransferases; Treatment Outcome	2010
Reduced cardio-respiratory coupling after treatment with nortriptyline in contrast to S-citalopram. Journal of affective disorders, 2010, Volume: 127, Issue:1-3 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Nonlinear Dynamics; Nortriptyline; Recurrence; Respiration; Vagus Nerve	2010
Early-life stress and antidepressants modulate peripheral biomarkers in a gene-environment rat model of depression. Progress in neuro-psychopharmacology & biological psychiatry, 2010, Aug-16, Volume: 34, Issue:6 Topics: Animals; Biomarkers; Brain-Derived Neurotrophic Factor; C-Reactive Protein; Citalopram; Corticosterone; Cytokines; Depressive Disorder; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Enzyme-Linked Immunosorbent Assay; Immunoassay; Maternal Deprivation; Nortriptyline; Proteomics; Rats; Stress, Psychological	2010
Dissociation of antidepressant-like activity of escitalopram and nortriptyline on behaviour and hippocampal BDNF expression in female rats. Journal of psychopharmacology (Oxford, England), 2011, Volume: 25, Issue:10 Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Citalopram; Female; Hippocampus; Nortriptyline; Rats; Rats, Sprague-Dawley; RNA, Messenger; Swimming	2011
Antidepressants and the resilience to early-life stress in inbred mouse strains. Pharmacogenetics and genomics, 2011, Volume: 21, Issue:12 Topics: Animals; Antidepressive Agents; Citalopram; Female; Genotype; Male; Maternal Deprivation; Mice; Mice, Inbred Strains; Nortriptyline; Social Environment; Stress, Psychological	2011
Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study. The Journal of clinical psychiatry, 2011, Volume: 72, Issue:11 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Longitudinal Studies; Male; Middle Aged; Multicenter Studies as Topic; Nortriptyline; Prognosis; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome	2011
Detection of amitriptyline, citalopram, and metabolites in porcine bones following extended outdoor decomposition. Journal of forensic sciences, 2012, Volume: 57, Issue:2 Topics: Amitriptyline; Animals; Antidepressive Agents; Bone and Bones; Chromatography, Liquid; Citalopram; Environment; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Nortriptyline; Postmortem Changes; Solid Phase Extraction; Swine	2012
Antidepressant use and risk of out-of-hospital cardiac arrest: a nationwide case-time-control study. Clinical pharmacology and therapeutics, 2012, Volume: 92, Issue:1 Topics: Aged; Antidepressive Agents; Case-Control Studies; Citalopram; Death, Sudden, Cardiac; Denmark; Depression; Female; Humans; Logistic Models; Male; Middle Aged; Nortriptyline; Odds Ratio; Out-of-Hospital Cardiac Arrest; Risk Assessment; Time Factors	2012
Pharmacoproteomic investigation into antidepressant response in two mouse inbred strains. Proteomics, 2012, Volume: 12, Issue:14 Topics: 14-3-3 Proteins; Adenine Nucleotide Translocator 1; Animals; Antidepressive Agents; Citalopram; Electrophoresis, Gel, Two-Dimensional; Female; Hippocampus; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Multivariate Analysis; Nortriptyline; Peroxiredoxins; Principal Component Analysis; Proteome; Proteomics; Reproducibility of Results; Stress, Psychological; Tandem Mass Spectrometry; Weaning	2012
Non-random dropout and the relative efficacy of escitalopram and nortriptyline in treating major depressive disorder. Journal of psychiatric research, 2012, Volume: 46, Issue:10 Topics: Antidepressive Agents; Bayes Theorem; Citalopram; Depressive Disorder, Major; Female; Follow-Up Studies; Humans; International Cooperation; Male; Models, Statistical; Nortriptyline; Patient Dropouts; Psychiatric Status Rating Scales; Time Factors	2012
Antidepressant-dependent mRNA changes in mouse associated with hippocampal neurogenesis in a mouse model of depression. Pharmacogenetics and genomics, 2012, Volume: 22, Issue:11 Topics: Animals; Antidepressive Agents; Citalopram; Depression; Disease Models, Animal; Hippocampus; Mice; Neurogenesis; Nortriptyline; RNA, Messenger	2012
SSRIs: a premature burial. Clinical pharmacology and therapeutics, 2013, Volume: 93, Issue:3 Topics: Antidepressive Agents; Citalopram; Death, Sudden, Cardiac; Female; Humans; Male; Nortriptyline; Out-of-Hospital Cardiac Arrest	2013
Response to "SSRIs: a premature burial". Clinical pharmacology and therapeutics, 2013, Volume: 93, Issue:3 Topics: Antidepressive Agents; Citalopram; Death, Sudden, Cardiac; Female; Humans; Male; Nortriptyline; Out-of-Hospital Cardiac Arrest	2013
Escitalopram versus nortriptyline: how to let the clinical GENDEP data tell us what they contained. Acta psychiatrica Scandinavica, 2013, Volume: 127, Issue:4 Topics: Antidepressive Agents; Citalopram; Clinical Trials as Topic; Depressive Disorder, Major; Humans; Nortriptyline; Psychometrics; Treatment Outcome	2013
Antidepressant effects of nortriptyline and escitalopram in the GENDEP study: is one better than the other? Acta psychiatrica Scandinavica, 2013, Volume: 127, Issue:4 Topics: Antidepressive Agents; Citalopram; Depressive Disorder, Major; Humans; Nortriptyline	2013
An electronic health records study of long-term weight gain following antidepressant use. JAMA psychiatry, 2014, Volume: 71, Issue:8 Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Body Mass Index; Bupropion; Citalopram; Electronic Health Records; Female; Humans; Male; Middle Aged; New England; Nortriptyline; Prospective Studies; Weight Gain; Young Adult	2014
Response to Kunte et al. The American journal of psychiatry, 2015, Feb-01, Volume: 172, Issue:2 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; C-Reactive Protein; Citalopram; Depressive Disorder, Major; Female; Humans; Inflammation; Male; Nortriptyline	2015
A new role for nortriptyline in depression associated with vascular disease? The American journal of psychiatry, 2015, Feb-01, Volume: 172, Issue:2 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; C-Reactive Protein; Citalopram; Depressive Disorder, Major; Female; Humans; Inflammation; Male; Nortriptyline	2015
Exploring the role of drug-metabolising enzymes in antidepressant side effects. Psychopharmacology, 2015, Volume: 232, Issue:14 Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cohort Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Depression; Female; Genotype; Humans; Male; Nortriptyline; Treatment Outcome	2015
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. Journal of affective disorders, 2015, Jul-15, Volume: 180 Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2015
Neurotrophic factors in depression in response to treatment. Journal of affective disorders, 2015, Sep-01, Volume: 183 Topics: Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Depressive Disorder, Major; Female; Humans; Male; Nortriptyline; Treatment Outcome; Vascular Endothelial Growth Factor A	2015
Melatonin Interaction Resulting in Severe Sedation. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2015, Volume: 18, Issue:2 Topics: Administration, Oral; Citalopram; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Deep Sedation; Dose-Response Relationship, Drug; Humans; Male; Melatonin; Nortriptyline; Oxycodone; Structure-Activity Relationship; Watchful Waiting; Young Adult	2015
Highly polygenic architecture of antidepressant treatment response: Comparative analysis of SSRI and NRI treatment in an animal model of depression. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2017, Volume: 174, Issue:3 Topics: Animals; Antidepressive Agents; Citalopram; Cyclic AMP Response Element-Binding Protein; Depression; Depressive Disorder; Disease Models, Animal; Female; Hippocampus; Male; Mice; Multifactorial Inheritance; Nortriptyline; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Transcriptome; Treatment Outcome	2017
Transcriptomic profiling of human hippocampal progenitor cells treated with antidepressants and its application in drug repositioning. Journal of psychopharmacology (Oxford, England), 2017, Volume: 31, Issue:3 Topics: Antidepressive Agents; Cell Line; Citalopram; Depressive Disorder, Major; Drug Repositioning; Hippocampus; Humans; Nortriptyline; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Stem Cells; Sulfonamides; Transcriptome	2017
Is Venlafaxine More Effective than Escitalopram and Nortriptyline in the Management of Painful Symptoms in Patients with Major Depression? Pharmacopsychiatry, 2018, Volume: 51, Issue:4 Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nortriptyline; Pain; Pain Measurement; Psychiatric Status Rating Scales; Time Factors; Venlafaxine Hydrochloride	2018
CGRP in a gene-environment interaction model for depression: effects of antidepressant treatment. Acta neuropsychiatrica, 2019, Volume: 31, Issue:2 Topics: Amygdala; Animals; Antidepressive Agents; Brain; Calcitonin Gene-Related Peptide; Citalopram; Depression; Disease Models, Animal; Frontal Lobe; Gene-Environment Interaction; Hippocampus; Male; Maternal Deprivation; Nortriptyline; Rats	2019
Depression-Associated Gene Cells, 2020, 07-31, Volume: 9, Issue:8 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Tricyclic; Cell Adhesion Molecules, Neuronal; Cells, Cultured; Citalopram; Depression; Disease Models, Animal; Down-Regulation; Gene Expression; Hippocampus; Mice; Neurons; Nortriptyline; Rats; Receptor, Fibroblast Growth Factor, Type 2; Selective Serotonin Reuptake Inhibitors; Signal Transduction	2020